临床外科杂志 ›› 2025, Vol. 33 ›› Issue (1): 92-96.doi: 10.3969/j.issn.1005-6483.20231678

• 论著 • 上一篇    下一篇

血清神经元特异性烯醇化酶、基质细胞衍生因子1和诱饵受体3联合在非小细胞肺癌病人预后评估中的临床意义

彭蓉蓉;卞家蓉;谈王蓉   

  1. 214200 江苏省宜兴市中医医院检验科 (彭蓉蓉、谈王蓉) ;江苏省苏北人民医院呼吸与危重症医学科(卞家蓉)
  • 收稿日期:2023-12-13 出版日期:2025-01-20 发布日期:2025-01-20
  • 通讯作者: 谈王蓉,Email:nwalvxuf@163.com
  • 基金资助:
    江苏省扬州市科技计划项目(YZ2017121)

Clinical significance of the combination of serum neuron specific enolase,stromal cell-derived factor-1,and decoy receptor 3 in prognostic evaluation of non-small cell lung cancer patients

PENG Rongrong,BIAN Jiarong,TAN Wangrong   

  1. Department of Laboratory Medicine,Yixing Hospital of Traditional Chinese Medicine,Yixing,Jiangsu Province 214200,China
  • Received:2023-12-13 Online:2025-02-24 Published:2025-01-20

摘要: 目的分析非小细胞肺癌(NSCLC)病人血清中神经元特异性烯醇化酶(NSE)、基质细胞衍生因子1(SDF1)和诱饵受体3(DcR3)表达水平及其对NSCLC病人预后的评估价值。方法前瞻性选取2019年3月~2020年3月宜兴中医医院及苏北人民医院收治的132例NSCLC病人为研究对象(NSCLC组),同时期我院的健康体检者132例作为对照组。采用酶联免疫吸附试验(ELISA)检测血清中NSE、SDF1和DcR3表达水平;采用多因素Logistic回归分析NSCLC病人预后不良的影响因素;采用受试者工作特征(ROC)曲线分析血清中NSE、SDF1和DcR3表达水平对NSCLC病人预后评估的价值。结果NSCLC组血清中NSE、SDF1和DcR3表达水平显著对照组,差异有统计学意义(P<0.05);肿瘤直径≥3cm、肿瘤分化程度为低分化、TNM分期为Ⅲ~Ⅳ期、淋巴结发生转移的NSCLC病人血清中NSE、SDF1和DcR3表达水平明显高于肿瘤直径<3cm、肿瘤分化程度为高/中分化、TNM分期为Ⅰ~Ⅱ期、淋巴结未发生转移的NSCLC病人,差异有统计学意义(P<0.05);与预后良好组比较,预后不良组NSCLC病人血清中NSE、SDF1和DcR3表达水平升高,发生淋巴结转移的比例升高,差异有统计学意义(P<0.05);多因素Logistic回归分析结果显示,NSE、SDF1、DcR3、淋巴结转移是NSCLC病人预后不良的影响因素(P<0.05);ROC曲线分析结果显示,血清中NSE、SDF1和DcR3水平评估NSCLC病人预后的曲线下面积(AUC)为0.852,较NSE、SDF1和DcR3单一指标评估价值更高。结论NSCLC病人血清中NSE、SDF1和DcR3表达水平显著升高,三者联合可作为评估NSCLC病人预后的指标。

关键词: 非小细胞肺癌, 神经元特异性烯醇化酶, 基质细胞衍生因子1, 诱饵受体3, 预后

Abstract: [Abstract]Objective To analyze the expression levels of neuron specific enolase (NSE),stromal cell derived factor-1 (SDF-1) and decoy receptor 3 (DcR3) in serum of patients with non-small cell lung cancer (NSCLC) and their prognostic value.Methods From March 2019 to March 2020,132 NSCLC patients admitted to Yixing Hospital of Traditional Chinese Medicine and the People’s Hospital of Subei were collected as the study subjects (NSCLC group),another 132 healthy examinees who came to our hospital were as the control group.enzyme linked immunosorbent assay (ELISA) was applied to detect the expression levels of NSE,SDF-1,and DcR3 in serum;multivariatenLogisticn regression was applied to analyze the influencing factors of poor prognosis in NSCLC patients; and receiver operating characteristic (ROC) curve was applied to analyze the value of serum NSE,SDF-1,and DcR3 expression levels in evaluating the prognosis of NSCLC patients.ResultsThe expression levels of NSE,SDF-1,and DcR3 in the serum of the NSCLC group were obviously higher than those of the control group,with statistical significance ( P<0.05);the expression levels of NSE,SDF-1,and DcR3 in the serum of NSCLC patients with a tumor diameter of ≥ 3 cm,low tumor differentiation,TNM staging of stage Ⅲ-Ⅳ,and lymph node metastasis were obviously higher than those of NSCLC patients with a tumor diameter of<3 cm,high/medium tumor differentiation,TNM staging of stage Ⅰ-Ⅱ,and no lymph node metastasis ( P<0.05);compared with the good prognosis group,the expression levels of NSE,SDF-1,and DcR3 in the serum of NSCLC patients in poor prognosis groupwere obviously increased,and the proportion of lymph node metastasis was obviously increased( P<0.05);the results of multivariatenLogisticn regression analysis showed that NSE,SDF-1,DcR3,and lymph node metastasis were the influencing factors for poor prognosis in NSCLC patients ( P<0.05);the results of receiver operating characteristic analysis showed that the area under the curve (AUC) of serum NSE,SDF-1 and DcR3 levels in evaluating prognosis of NSCLC patients was 0.852,which was more valuable than the single index of NSE,SDF-1 and DcR3.Conclusion The expression levels of NSE,SDF-1,and DcR3 in the serum of NSCLC patients are obviously increased,and the combination of the three can be used as a prognostic indicator for NSCLC patients.

Key words: nonsmall cell lung cancer, neuronspecific enolase, stromal cellderived factor 1, decoy receptor 3, prognosis

[1] 赵国栋, 黄刚. 肾移植受者BK多瘤病毒感染临床诊疗国际指南(第2版)解读[J]. 临床外科杂志, 2025, 33(1): 63-66.
[2] 严萍萍, 张绍东, 郭皎亮, 窦燕东. Luminal B型乳腺癌组织中XAF1、PCK1表达及与病人预后的关系[J]. 临床外科杂志, 2025, 33(1): 97-101.
[3] 李林, 陈楚鹰, 何久圣, 张浩. 切开复位内固定术联合韧带修复治疗踝关节骨折合并下胫腓前韧带断裂的疗效分析[J]. 临床外科杂志, 2025, 33(1): 105-108.
[4] 赵洁 江帆 祁涛 闫丽娟 简鸽 刘梦婷. 非小细胞肺癌表皮生长因子受体靶向治疗后病人血清微小RNA-30a-5p和微小RNA-129-5p表达与疗效的关系[J]. 临床外科杂志, 2024, 32(9): 923-926.
[5] 秦乐 衡怡鑫 徐佳鑫 黄宁 邓胜和 古俊楠 毛富巍 薛一凡 蒋振兴 王军 程登龙 曹英豪 蔡开琳. 结直肠癌合并肝骨转移病人预后评分系统的开发和验证:一项回顾性队列研究[J]. 临床外科杂志, 2024, 32(9): 947-954.
[6] 于青 郑媛媛 张莉 张志华. 药物涂层球囊经皮腔内血管成形术对下肢动脉长段闭塞病人临床指标及预后的影响[J]. 临床外科杂志, 2024, 32(9): 976-979.
[7] 康树宏 吕峰 倪云峰 贠俊茹. 微小核糖核酸-27a、微小核糖核酸-1299预测食管癌病人术后预后的临床价值[J]. 临床外科杂志, 2024, 32(8): 803-806.
[8] 王娜 孙伟伟 邢国靖 赵金雷 孙群. 血清基质金属蛋白酶-9、热休克蛋白47水平与急性脑出血术后预后的关系[J]. 临床外科杂志, 2024, 32(8): 818-821.
[9] 何朝滨 李升平. 不可逆电穿孔治疗胰腺癌[J]. 临床外科杂志, 2024, 32(7): 673-676.
[10] 徐业成 傅德良. 胰腺全切除术在胰腺癌治疗中的应用[J]. 临床外科杂志, 2024, 32(7): 677-679.
[11] 黄如敬 鲁洪岭 吴超 杨洪娟 尹晓明 赵阳 康华薇 田菲 孙云川. 非小细胞肺癌病人血清miR-326和miR-623表达与临床病理特征及预后的关系[J]. 临床外科杂志, 2024, 32(7): 706-710.
[12] 冯南 林鸿千 郭义锦 王亚娇. 食管印戒细胞癌病人预后不良危险因素分析及列线图预测模型构建[J]. 临床外科杂志, 2024, 32(7): 712-715.
[13] 路慧青 赵友为 刘巍. 膀胱癌病人血清miR-143-3p、ATG2B水平与临床病理及预后生存的关系[J]. 临床外科杂志, 2024, 32(7): 757-761.
[14] 高超 戴希勇 蒋钰辉 刘小玉 李晶 熊浩. 非小细胞肺癌病人血清中miR-455、miR-383表达水平及其临床诊断价值分析[J]. 临床外科杂志, 2024, 32(6): 607-610.
[15] 尹英爱 秦桂萍 华玉兰 曹敏 齐淋喆 白苏日娜 杨悦. 伴AFP明显升高的高级别胎儿型肺腺癌一例[J]. 临床外科杂志, 2024, 32(6): 619-620.
Viewed
Full text
38
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 38

  From Others local
  Times 4 34
  Rate 11% 89%

Abstract
77
Just accepted Online first Issue
0 0 77
  From Others local
  Times 75 2
  Rate 97% 3%

Cited

Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
No Suggested Reading articles found!